Today breast cancer is the most commonly seen cancer among women. The death due to breast cancer among women comes as the second leading cause after lung cancer. The risk of developing breast cancer is one in eight women in developed countries (1).
Introduction
Today breast cancer is the most commonly seen cancer among women. The death due to breast cancer among women comes as the second leading cause after lung cancer. The risk of developing breast cancer is one in eight women in developed countries (1) .
There are more than 1,000,000 breast cancer cases each year, and almost half of these are in less developed countries (20) .
In the United States of America (USA) the rate of breast cancer and other cancers increased between 1973 and 1990. All-sites cancer incidence and mortality fell in the period 1991 through 1995. After the rapid increase in breast cancer incidence rates that accompanied the widespread introduction of the mammography in the 1980s, breast cancer mortality is now decreasing at a rate of approximately 1 % per year (16) .
There is not enough information about cancer statistics and outcomes for our country. In this study we aimed to analyze breast cancer cases retrospectively followed in two different University Hospital in Turkey within the last ten years.
Patients and methods
The records of women with diagnosis of breast cancer that followed in Hospitals of Selcuk University and Kocaeli University were examined in a retrospective way. The age of the patients, their first complaints or symptoms, physical examination findings, used diagnostic methods, localization of the tumors, axillary lymph node status, histopathological types of the tumors, clinical stages and survival periods of the patients were recorded.
Results
The median age of the cases was 49.0±12.5 (range: 18-90 years) and distribution according to the age groups are shown in Table 1 . Breast cancer was observed more common in the patients between the ages of 40-49 (32.5 %).
Generally the patients (80.8 %) were admitted to the hospital as a result of the lump in the breast. The lumps were painless in most of the cases (80.9 %). The other complaints of the patients are shown in Table 2 .
While mass was palpated in 275 (85 %) cases, axillary lymph nodes were palpated only in 174 (50 %) cases. Peau D'orange appearance and nipple retraction were seen in 44 (13.6 %) and 27 (8.3 %) cases, respectively. Physical examination findings of the patients are shown in Table 3 .
According to TNM classification the most commonly seen stage was IIA, 98 cases (30.2 %) and followed by IIB, 78 cases (24.0 %). The clinical stages of the patients according to TNM classification are shown in Table 4 .
Complete blood count and biochemical parameters including electrolytes, liver and renal function tests were checked in all cases. Co morbid diseases like hypertension in 58 (17.9 %) cases, heart disease in 7 (2.2 %), diabetes mellitus in 15 (4.6 %) cases, gallbladder stone in 7 (2.2 %) cases, anemia in 35 (10.8 %) cases, renal insufficiency in one case and Parkinson disease in one case were recorded. Elevated liver function tests in 20 cases (6.2 %) and hypercalcaemia in 12 (3.7 %) cases were established.
Bilateral mammography, abdominal ultrasonography and chest X-ray were done in all cases and computed tomography of thorax and abdomen were done in necessary situations. Scintigraphy of all bones in the body were taken At the first examination distant metastasis were found only in 38 (12.1 %) patients. Metastasis locations were found as bone in 11 cases, supraclavicular region in 11 cases, liver in 10 cases, lung in 3 cases, both liver and lung in 2 cases and both liver and bone in 2 cases. The tumor mass localizations were more in the left breast of the patients (53.4 %). When the all quadrants examined the tumors were established mostly in upper external quadrants of the breasts (47.6 %). The second most often established localization of the tumors was beneath areola region (16.4 %). In 73 of the cases (22.5 %) clinically inoperable breast cancer were present. After the biopsy, neoadjuvant systemic chemothrerapy was given to 60 cases and 12 cases were referred to radiotherapy (RT) first. Initial surgical procedure and then systemic chemotherapy was applied to the rest of the 252 (77.8 %) cases. As systemic chemotherapy CMF (Cyclophosphamide, Methotrexate, 5-Fluorouracil) or CAF (Cyclophosphamide, Adriablastina, 5-Fluorouracil) were given to 81.2 % of the patients according to breast cancer stage and patient's clinical situation. Tamoxifen was given to the patients in whom estrogen receptor positivity shown in breast biopsy specimen. Modified radical mastectomy and axillary dissection were performed in 216 (85.7 %) patients as the most frequent surgical operation procedure. Performed surgical operations to the patients are shown in Table 6 . In 13 cases (4.0 %) surgical operations were performed after down staging of the cancer by neoadjuvant chemotherapy or radiotherapy.
In 273 cases (84.4 %) infiltrative ductal carcinoma and in 38 cases (11.7 %) lobular carcinoma were diagnosed histopathologically. Histopathological results of the tumors are shown in the Table 7 . In three cases in which infiltrative ductal carcinoma was diagnosed (1 %) also Pagets disease were found at the nipples of the breasts. Axillary dissection was done in 236 cases and metastases were found in 201 of them.
Primary surgery was performed in 76.5 % of the patients, systemic chemotherapy was given to 19.5 % of the patients and radiotherapy was employed to 4 % of the patients. Estrogen receptor status was positive in 41.16 of the cases. Tamoxifen was given to the patients as 20 mg/day in whom estrogen receptor status was found as positive.
One or more postoperative complications was developed in 70 (21.6 %) cases and the most frequent complication was seroma and seen in 69 (21.3 %) cases. The other complications were skin necrosis in 29 (8.9 %) cases, infection of incision line in 15 (4.6) cases and nerve damage in 15 (4.6 %) cases.
We were able to contact with the patients or relatives through the telephone and recorded the last visits of the patients from the files. It was seen that 246 (75.9 %) patients were still alive and 78 (24.1 %) patients were died during 5 years period. When the died patients analyzed according to the their clinical stages at admission; it was found out that 4 of them in stage IIA, 5 of them in stage IIB, 7 of them in stage IIIA, 9 of them in stage IIIB, 53 of them in stage IV.
Discussion
Breast cancer is the second most frequent cause of cancer death among women and accounts for 15 % of all cancer deaths among women; only lung cancer causes more deaths (11) . It is assumed that in year 2000 one million new cases and over 400,000 deaths would appear in the world (8) . The American Cancer Society estimated that 192,000 cases and 40,000 deaths would occur among U.S. women during 2001 (13) . Although the frequency of breast cancer varies from region to region, in recent years there is a significant increase in allover the world (8) . Difference in the frequency of breast cancer between the developed and rest of the world have decreased. USA, Canada, Spain, and Sweden were countries in which breast cancer is highest. As one of the leading cause of cancer death among all women worldwide, breast cancer accounted for more than 300,000 deaths In 1990: 174,100 deaths occurred in developed countries and 139,500 occurred in developing countries (21) . Death rates due to breast cancer were low in Asia, Africa and central America; intermediate in South America and southern Europe; and highest in western Europe and North America (13) . This difference is most significant among the women after menopause. Likewise, there are differences between the different ethnic groups.
Probability of having breast cancer and dying from it for an American woman is calculated as 10 % and 3-4 % respectively. This assessment was approximated between the birth and 110 years old. It is known that the illness increases with the age. Breast cancer is rare in woman younger than 30 year-old, however rapidly increases after these ages. Although there is a slight decrease through the menopause period, following these years slow but an increasing tendency is seen (22) . These differences are related to the effects of the environment, life styles, and socio-economical conditions of the women (9, 19) .
In our study group, most of the patients were between the ages of 40-49 (30.9 %). Genetical, environmental, hormonal, sociological and psychological factors have effect on breast cancer development (9, 14) . Socio-cultural levels of women have an important role in mortality of the breast cancer patients. The high stage level is more prevalent in low educated people and high rate of death is observed among them (4, 24) .
The frequency of breast cancer rises two-three times in women who have relative with breast cancer. This risk is doubled if the mother had history of breast cancer and 2.5 times greater if their sisters had the disease. The existence of cancer in one breast, early menarche, late menopause, late first pregnancy age, being subjected to radiation, obesity, extreme alcohol intake, high fatty diet have been researched risk factors for breast cancer (3, 17) . Because of the inadequate records and laboratory results of our patients, the role of these factors could not be established in this study. The association of breast cancer with pregnancy is rare. It is defined as the occurrence of breast cancer during pregnancy or during the year following delivery (15) . In our series, a case with inoperable breast cancer was diagnosed and referred for chemotherapy and another had a history of full term childbirth of 4 months ago and breast mass complaint during the third trimester of the pregnancy.
The leading first complaint of our breast cancer patients was painless and hard lump within the breast. In addition to breast lump, skin changes like orange peel appearance, satellite nodules, ulceration, nipple discharge, lesions similar to eczama, lymph nodes in axillary and supraclavicular regions were found in clinical examination of the patients. In our patients lump within the breast and lymph nodes in axillary region could be palpated in 86 % and 53 % of the cases, respectively, by physical examination.
Breast cancer was diagnosed more often in upper exterior quadrant (47.2 %) and beneath the areola region (16.4 %). The excessive breast mass in upper exterior quadrant and connection point of the nipples are the reasons for this distinction pattern.
According to the clinical stage, the most common one stage IIA (30.2 %) and the least one stage I (2.8 %) in our patients. It was established that 74 % of the cases had one of the stages of IIA, IIB or IIIA. Seventy-two cases (23.5 %) were assessed as inoperable.
Established prognostic and predictive factors in breast cancer patients are age, race, tumor size, nodal status, tumor subtype, standard pathological grade, estrogen receptor, progesterone receptor, mitotic rate (1). The standard prognostic factors that are used in treatment of the breast cancer are the status of axillary lymph nodes, histological subtype, the tumor size, nuclear and histological grade, the presence of estrogen and progesterone receptors, the measurement of the proliferation. It was stated that the other factors other than these has no clinical benefit (18) .
Axillary region is the main drainage area for the breast. In the 50 % breast cancer cases that are diagnosed clinically, axillary lymph node metastasis was observed histopathologically. The status of axillary lymph node metastasis is not directly related to the dimension of the primary tumor. Even in the small tumors like 0.5 cm diameter, the risk of axillary lymph node metastasis is as 20 %. Localization of the tumor within the breast helps to determine the risk of axillary lymph node metastasis. It was known that tumors of external quadrant cause the axillary lymph node metastasis more than one of internal quadrant. In addition, it was shown that the number of the lymph nodes with metastasis is independent from the size of the tumor and directly related to disease outcome (6, 23) . Axillary lymph node metastasis in our patient group was found out as 66.7 %. This number is apt with the data in the literature.
In early postoperative period the most common morbidity was found as seroma in the patients (22.4 %). Other complications of our cases were appropriate with the literature knowledge.
Surgical treatment, systemic chemotherapy, radiotherapy, hormonal therapy can be used for treatment of breast cancer. One of these treatment options or combinations might be preferred according to the patient's clinical status, tumor stage and characteristics of the tumor. It has been advised to use Tamoxifen in all estrogen-receptor-positive premenopausal and post-menopausal women (2, 5, 7, 10, 12) . Primarily 76.5 % of our patients were undergone surgery, 19.5 % undergone systemic chemotherapy and 4 % undergone through radiotherapy. Surgical procedure was performed in 4 % of the cases after neoadjuvant chemotherapy or radiotherapy in whom down staging was achieved. After the surgery, systemic chemotherapy was given to 81.2 of the cases. Estrogen-receptor was found positive in 41.16 of the cases and Tamoxifen was given to them as hormonal therapy.
Five-year relative survival rates of breast cancer patients improved from 75 % during mid-1970s to 86 % during 1990s. Survival rates varied markedly by stage at diagnosis, from 89 % or more in women with localized disease to 22 % or less in women whose tumors have distant spread (13) . In our cases, 5-year relative survival rate was found as 75.9 %. Breast cancer screening is not established in our country. So that the number of breast cancer patients with early stages is lesser than the patients with higher stages in our series. The patients apply to the hospitals when the disease has been progressed and give more complaints to them.
Conclusion
As a conclusion it can be predicted that breast cancer, as in the world generally, show the tendency of increase in our country and in our region. The object must be to go beyond the predictions with the real data and analyze the situation we are in, know the risk factors well and enlighten the people under the threat of this disease. The small number of the cases, which diagnosed in early stage shows that breast cancer is not yet well known by the people (especially women) in the region. The aim of this study is to put down the insufficiency in this matter. We are in the opinion that information and data insufficiency would be put away with the countrywide studies about breast cancer.
Both international and intranational breast cancer incidences and mortality rates are different. Incidence rate differences between countries show the importance of inherent genetic risk in breast cancer etiology and lifestyle factors can dramatically affect risk. Incidence rate differences within countries arise in part because of differential access to and utilization of health care resources such as screening and diagnosis. We should extend therapeutic advances to all segments of the population.
